Press Releases

Epic Sciences Announces Presentation of Three Studies on Novel CTC Liquid Biopsy Assays for Metastatic Prostate Cancers and Bladder Cancers at 2015 ASCO GU Cancer Symposium

SAN DIEGO, Feb. 23, 2015 /PRNewswire/ -- Epic Sciences announced today that results from studies in metastatic castration resistant prostate cancer (mCRPC), neuroendocrine prostate cancer (NEPC) and muscle-invasive, metastatic bladder cancers using Epic's…

Epic Sciences to Present at Personalized Medicine World Conference 2015 on the Use of Circulating Tumor Cells as Cancer Biomarkers

SAN DIEGO – January 26, 2015 – Epic Sciences, a precision diagnostics company dedicated to improving the treatment of cancer, today announced that Murali Prahalad, Ph.D., president and CEO, is scheduled to present at the Personalized Medicine World…

Epic Sciences Receives CLIA Certification for its Cancer Diagnostics Laboratory

SAN DIEGO – January 8, 2015 – Epic Sciences announced today that the company has received certification under the Clinical Laboratory Improvement Amendments of 1988 (CLIA). Under the “deemed status” provision of the U.S. Department of Health and Human…

Epic Sciences to Present at the Piper Jaffray Healthcare Conference

SAN DIEGO and NEW YORK CITY – November 26, 2014 – Epic Sciences, a precision diagnostics company dedicated to improving the treatment of cancer, today announced that Murali Prahalad, Ph.D., president and CEO, will present at the 26th Annual Piper Jaffray…

Epic Sciences to Present Data on a Combination CTC and cfDNA Assay for Molecular Targets of Non-Small Cell Lung Cancer Therapies at the 26th EORTC-NCI-AACR Symposium

SAN DIEGO and BARCELONA, Spain, Nov. 17, 2014 -- Epic Sciences will present data describing the detection of clinically actionable non-small cell lung cancer (NSCLC) biomarkers, including EGFR, KRAS, ALK, MET, RET and ROS1, utilizing both circulating…

Epic Sciences Appoints Toni Wayne as Vice President of Human Resources

SAN DIEGO, Nov. 13, 2014 /PRNewswire/ -- Epic Sciences announced today the appointment of Toni Wayne as vice president of human resources. Ms. Wayne has more than 20 years of experience as a senior level human resources executive in diverse life sciences…

Epic Sciences to Present on Characterizing PD-L1 in Circulating Tumor Cells of Non-Small Cell Lung Cancer Patients at the 26th EORTC-NCI-AACR Symposium

SAN DIEGO and BARCELONA, Spain – November 12, 2014 – Epic Sciences will present an analysis of PD-L1 protein expression on circulating tumor cells (CTCs) from non-small cell lung cancer (NSCLC) patients. The poster presentation will take place November 19…

Epic Sciences Appoints Glen Freiberg as Vice President of Regulatory Affairs and Quality Assurance

SAN DIEGO – September 12, 2014 – Epic Sciences announced today the appointment of Glen Paul Freiberg, RAC as vice president of regulatory affairs and quality assurance. Mr. Freiberg has more than 35 years of FDA-related experience and is recognized as a…

Epic Sciences Announces Series C Financing to Advance Essential Cancer Diagnostics for Personalized Medicine

SAN DIEGO – July 30, 2014 – Epic Sciences, Inc. (“Epic”), a privately held biotech company that designs and develops novel diagnostics to personalize and advance the treatment and management of cancer, announced today the completion of a $30 million…

Epic Sciences Appoints Greg Lucier as Chairman of the Board of Directors

SAN DIEGO – July 30, 2014 – Epic Sciences, Inc. (“Epic”), a private biotech company that designs and develops novel diagnostics to personalize and advance the treatment and management of cancer, announced today the appoint of Gregory T. Lucier as chairman…